Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-01-25 @ 7:09 PM
Study NCT ID:
NCT05160168
Status:
TERMINATED
Last Update Posted:
2024-06-05
First Post:
2021-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Sponsor:
Theseus Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gastrointestinal Stromal Tumors (GIST) | View |
| None | Neoplasms, Connective Tissue | View |
| None | Neoplasms, Connective and Soft Tissue | View |
| None | Neoplasms by Histologic Type | View |
| None | Neoplasms | View |
| None | Gastrointestinal Neoplasms | View |
| None | Digestive System Neoplasm | View |
| None | Digestive System Disease | View |
| None | Gastrointestinal Diseases | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Gastrointestinal Stromal Tumor | View |
| None | GIST | View |
| None | KIT inhibitor | View |
| None | THE-630 | View |
| None | THE630 | View |
| None | THE 630 | View |
| None | GIST TKI | View |
| None | GIST tyrosine kinase inhibitor | View |
| None | GIST treatments | View |
| None | GIST Imatinib relapse | View |
| None | GIST Sunitinib relapse | View |
| None | GIST Regorafenib relapse | View |
| None | GIST Ripretinib relapse | View |
| None | PDGFRA | View |
| None | KIT-mutant GIST | View |
| None | Advanced GIST | View |